Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
  • Eye health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • KABP® Intensive G.I
  • KABP® Urinary Tract Support
  • KABP® Mature Immune Defense®
  • KABP® DENTALAC
  • LipiGO®
  • KABP® Digest
  • Brain (DR7)®
  • DR7
  • KABP® DENTISANI
  • KABP® Baby Colic
  • KABP® Vaginal Health Balance
  • KABP Cardio
  • KABP®-051
  • AB-Protears®
  • Kaneka Probiotics L.sakei proBio65 ®
  • KABP 21®
  • KABP® MENOPAUSE
Products to Clinical Evidence (mobile)
  • Probiotic Properties of Bifidobacterium longum KABPTM 042 and Pediococcus pentosaceus KABPTM 041 Show Potential to Counteract Functional Gastrointestinal Disorders in an Observational Pilot Trial in Infants

    2022

    Astó E et al.

    Read
  • Patient characteristics influencing infant colic amelioration under a probiotic treatment

    2019

    Navarro-Tapia E, et al

    Read
  • Probiotic treatment with AB-KOLICARE causes changes in the microbiota which correlate with a reduction in crying time

    2017

    Tintore M, et al

    Read
  • Pediococcus pentosaceus CECT 8330 and Bifidobacterium longum CECT 7894 show a trend towards lowering infantile excessive crying syndrome in a pilot clinical trial

    2015

    Santas JM, et al

    Read
  • Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults

    2014

    Szajewska H, et al.

    Read
  • Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a syste- matic review and meta-analysis

    2012

    Hempel S, et al.

    Read